mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.09 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.09 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |